Review
Immunologic markers and the diagnosis of prostatic cancer
- PMID: 6203206
Item in Clipboard
Review
Immunologic markers and the diagnosis of prostatic cancer
Urol Clin North Am.
1984 May.
Abstract
The authors review recent developments in the immunodiagnosis of prostatic cancer. Monoclonal antibodies to prostatic acid phosphatase, prostate-specific antigen, and several human prostate and prostate-cancer-related components are available. Prostatic acid phosphatase and prostatic antigen assays are still the only immunologic tools with clinical applications.
Similar articles
-
Prostate cancer-associated markers.Immunol Ser. 1990;53:339-56. Immunol Ser. 1990. PMID: 1713065 Review.
-
Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.Int Adv Surg Oncol. 1982;5:29-49. Int Adv Surg Oncol. 1982. PMID: 6178696 No abstract available.
-
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.J Natl Cancer Inst. 1982 Jan;68(1):99-105. J Natl Cancer Inst. 1982. PMID: 6172628
-
[Tumor markers in prostate cancer].Gan To Kagaku Ryoho. 1994 Sep;21(12):1915-22. Gan To Kagaku Ryoho. 1994. PMID: 7521999 Japanese.
-
Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers.Clin Physiol Biochem. 1988;6(5):241-52. Clin Physiol Biochem. 1988. PMID: 2465864 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical